Alliance Global Partners Comments on OTC:GTBIF Q2 Earnings

Green Thumb Industries Inc. (OTC:GTBIFFree Report) – Stock analysts at Alliance Global Partners decreased their Q2 2025 EPS estimates for shares of Green Thumb Industries in a note issued to investors on Wednesday, October 30th. Alliance Global Partners analyst A. Grey now expects that the company will earn $0.05 per share for the quarter, down from their prior forecast of $0.06. The consensus estimate for Green Thumb Industries’ current full-year earnings is $0.36 per share.

Several other research analysts have also weighed in on GTBIF. Craig Hallum raised Green Thumb Industries to a “strong-buy” rating in a research report on Monday, September 16th. Ventum Cap Mkts upgraded shares of Green Thumb Industries to a “strong-buy” rating in a report on Tuesday, August 6th.

View Our Latest Report on GTBIF

Green Thumb Industries Trading Down 1.5 %

OTC:GTBIF opened at $10.08 on Thursday. The firm has a 50-day moving average of $10.33. Green Thumb Industries has a 52-week low of $7.68 and a 52-week high of $16.33. The firm has a market capitalization of $2.13 billion, a P/E ratio of 36.54 and a beta of 1.40.

Green Thumb Industries Company Profile

(Get Free Report)

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RHYTHM brands.

Read More

Receive News & Ratings for Green Thumb Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Green Thumb Industries and related companies with MarketBeat.com's FREE daily email newsletter.